ArticleDisease markers2024

JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib.

Indra Wijaya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.